Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new Revision label (v3.3.4) replacing the previous v3.3.3. This is a UI version update and does not modify any study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a Locations section with Anhui, Guangdong, Heilongjiang, Jiangsu, and Zhejiang, and removed the individual location subsections. This update is reflected in Revision: v3.3.3.SummaryDifference0.7%

- Check45 days agoChange DetectedThe study status was updated to Completed and the page now includes complete details for the Fruquintinib+paclitaxel and Fruquintinib placebo+paclitaxel arms, including start, completion dates, and related treatment descriptions.SummaryDifference1%

- Check52 days agoChange DetectedThe PubMed publications notice on the study page was updated to indicate automatic filling from PubMed, and the Revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe funding status and operating updates notice has been removed from the page, so it now presents only the study details.SummaryDifference0.4%

- Check81 days agoChange DetectedNo significant changes to the study details, eligibility criteria, outcomes, or locations; only minor formatting and layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.